Dr Mary Sartor to present research on LMA and the 10B3 monoclonal antibody developed by HaemaLogiX at ASH 2021

1/1

5 November 2021

HaemaLogiX Pty Ltd, the Westmead Institute for Medical Research and TPL Path Labs GmbH will present a poster entitled: 'A Novel B Cell Antigen Designated Lambda Myeloma Antigen (LMA) Has Been Identified Using Two Fully Human Monoclonal Antibodies (Mabs) That Bind to Similar Epitopes on Plasma Cells from Patients with Plasma Cell Dyscrasias' at the 63rd annual American Society of Hematology meeting in Atlanta, Georgia in mid-December. Ahead of the meeting, the abstracts have been published online and the full poster will be available after December 11.